Physician profile
Stephen Thorp
NPI 1790136158
$14,066.83
in general payments reported to CMS, 2019-2025
11 companies · $516 in 2025
The $516 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $10K · 2023: $175 · 2024: $2,958 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,360 · Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,359.83 |
| Food and Beverage | $1,289.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,207.10 | 2022 | |
| Medtronic, INC. | $1,415.80 | 2024-2025 | Corevalve Evolut R |
| Bolton Medical INC | $1,272.35 | 2024 | Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $497.89 | 2023-2025 | Konect Resilia, Inspiris Resilia Aortic Valve, Edwards Intuity Elite Valve System |
| W. L. Gore & Associates, INC. | $173.25 | 2024 | Product In Development |
| Abiomed | $143.06 | 2024-2025 | Impella |
| Davol INC. | $129.88 | 2022 | |
| Atricure, INC. | $108.65 | 2025 | Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $80.54 | 2022 | |
| Ethicon US, LLC | $23.31 | 2025 | Echelon Endopath |
| Bard Peripheral Vascular, INC. | $15.00 | 2025 | Lutonix Drug Coated Balloon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Thorp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.